Fight Over Waze? Way
Health Care: Drugs
Chembio Diagnostics Inc. (CEMI: NASDAQ)
$4.50 0.00 | 0.00%
05/24/13 - 03:59 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:45.00
Price Earnings Comparisons:
| CEMI | Sector Avg. | S&P 500 |
|---|---|---|
| 45.00 | 45.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -19.35 | 744.28 | 1700.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 32.10 | 0.85 | 0.23 |
| Net Income | 2.05 | 0.44 | |
| EPS | -84.70 | 0.00 | 0.00 |
Earnings for CEMI:
| EBITDA | 1.98M |
| REVENUE | 25.61M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.02 | $0.03 | $0.11 | $0.18 |
| Number of Analysts | 3 | 3 | 3 | 3 |
| High Estimate | $0.03 | $0.04 | $0.15 | $0.30 |
| Low Estimate | $-0.05 | $0.02 | $0.04 | $0.08 |
| Prior Year | $0.04 | $-0.06 | $0.11 | $0.11 |
| Growth Rate (Year over Year) | -150.00% | 150.00% | -3.03% | 71.87% |
Portfolios with CEMI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
Latest CEMI Headlines from TheStreet
- Chembio Commences CLIA Waiver Studies For DPP(R) HIV 1/2 Assay 04.18.13 | 08:04 am
- Chembio Announces Closing Of $6 Million Public Offering Of Common Stock 04.03.13 | 03:04 pm
- Chembio Announces Pricing Of $6.0 Million Public Offering Of Common Stock 03.28.13 | 06:03 am
- Chembio Announces Public Offering Of Common Stock 03.27.13 | 04:03 pm
- Chembio To Present At The ROTH Capital Partners 25th Annual Growth Stock Conference 03.14.13 | 08:03 am
- Chembio Diagnostics Reports Fourth Quarter And Full-Year 2012 Financial Results 03.07.13 | 04:03 pm
- Chembio To Host Conference Call To Discuss 2012 Financial Results 02.22.13 | 08:02 am
- Chembio Announces U.S.D.A. Approval Of Tests For Detection Of Bovine Tuberculosis In Captive Elk And Deer 01.29.13 | 08:01 am
- Chembio To Present At Sidoti & Company, LLC 2013 Micro-Cap Conference 01.04.13 | 08:01 am
- Chembio Receives FDA Approval For DPP(R) Point-of-Care HIV 1/2 Rapid Test 12.21.12 | 08:12 am
Press Releases for CEMI
- Chembio Diagnostics, Inc. Investor Presentation Now Available For On-demand Viewing At RetailInvestorConferences.com - PR Newswire 02.06.12 | 10:02 am
- Chembio Presenting At Biotech Conference - PR Newswire 01.09.12 | 08:01 am
- Chembio Provides Business Update - PR Newswire 01.03.12 | 08:01 am
- Chembio To Host Conference Call To Discuss 3rd Quarter 2011 Financial Results - PR Newswire 10.20.11 | 08:10 am
- Chembio Diagnostics' CFO Richard J. Larkin Among The Recipients Of "2011 CFO Of The Year" Award From Long Island Business News - PR Newswire 08.18.11 | 08:08 am
- Chembio To Host Conference Call To Discuss 2nd Quarter 2011 Financial Results - PR Newswire 07.20.11 | 08:07 am
- Chembio To Sponsor AIDS Walk New York 2011 - PR Newswire 05.11.11 | 08:05 am
- Chembio Corrects Previous Press Release - PR Newswire 04.21.11 | 05:04 pm
- Chembio Files PMA Module With FDA For DPP® HIV Test - PR Newswire 04.19.11 | 08:04 am
Partner Headlines for CEMI
- Q3: DPP Sales Up 49% Despite Revenue Miss - Analyst Blog - Zacks 11.13.12 | 06:11 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 06:08 pm
- USPSTF Decision Could Benefit CEMI - Analyst Blog - NASDAQ 08.21.12 | 03:08 pm
- Med-tech Companies to Watch in 2012 - Analyst Blog - Zacks 01.09.12 | 07:01 am
- Q1 2011 Financial Results... - Analyst Blog - Zacks 05.06.11 | 09:05 am
- Major Milestone for Chembio - Analyst Blog - Zacks 07.01.10 | 06:07 pm
- Chembio Diagnostics Inc. - Bull of the Day - Zacks 06.22.10 | 01:06 am
